The serotonin signaling system: from basic understanding to drug development for functional GI disorders

Cites (250)

Items 201–250 of 250

1. Ability of Mosapride to Bind to 5-HT4 Receptor in the Human Stomach
   Sakurai-Yamashita Yasuko, Takada Kohei, Takemura Keiko · 1999 · The Japanese Journal of Pharmacology
2. 5-Hydroxytryptamine4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea pig ileum: Antagonism by tropisetron and DAU 6285
   Marcello Tonini, Stefano Massimo Candura, L. Onori · 1992 · Life Sciences
3. Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy
   Hideki Asakawa, Isao Hayashi, Takeshi Fukui, Katsuo Tokunaga · 2003 · Diabetes Research and Clinical Practice
4. Living and commuting in intestinal crypts
   Melissa Hirose Wong, Thaddeus S. Stappenbeck, Jeffrey I. Gordon · 1999 · Gastroenterology
5. The effects of an acute serotonergic challenge on brain–gut responses in irritable bowel syndrome patients and controls
   T. O. C. Kilkens, Adriaan Honig, Durk Fekkes, Robert J. Brummer · 2005 · Alimentary Pharmacology & Therapeutics
6. Cisapride accelerates gastric emptying and mouth-to-caecum transit of a barium meal
   R. Baeyens, A.J.M. Reyntjens, Marleen H. Verlinden · 1984 · European Journal of Clinical Pharmacology
7. Adrenergic modulation of the release of 5‐hydroxytryptamine from the vascularly perfused ileum of the guinea‐pig
   Kurt Racké, Harald Schwörer, Heinz J. Kilbinger · 1988 · British Journal of Pharmacology
8. Investigation of serotonin type 4 receptor expression in human and non-human primate gastrointestinal samples
   Robert M. Mader, Thomas Kocher, Jörg Haier, Grazyna Wieczorek, Hans‐Juergen Pfannkuche, Moriko Ito · 2006 · European Journal of Gastroenterology & Hepatology
9. Molecular, functional, and pharmacological targets for the development of gut promotility drugs
   Sushil K. Sarna · 2006 · American Journal of Physiology-Gastrointestinal and Liver Physiology
10. �ber den 5-Hydroxytryptamin-(Enteramin)-Gehalt des Magen-Darmtraktes bei den Wirbeltieren
    V. Erspamer · 1953 · Die Naturwissenschaften
11. Effects of a 5‐HT4 receptor agonist on oesophageal function and gastro‐oesophageal reflux: studies using combined impedance‐manometry and combined impedance‐pH
    Radu I. Tutuian, Inder Mainie, Richard Allan, Kate Hargreaves, A. AGRAWAL, Janice Freeman, Jeremy D. Gale, Donald O. Castell · 2006 · Alimentary Pharmacology & Therapeutics
12. Intestinal motility changes in rats after enteric serotonergic neuron destruction
    Victor M. Piñeiro-Carrero, Mary Heimerdinger Clench, Robert H. Davis · 1991 · American Journal of Physiology-Gastrointestinal and Liver Physiology
13. Immunocytochemistry of serotonin-containing nerves in the human gut
    Susy S. Kurian, Gian‐Luca Ferri, Johan De Mey · 1983 · Histochemistry and Cell Biology
14. The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis
    Alasdair D R Mackie, C. Ferrington, S. COWAN · 1991 · Alimentary Pharmacology & Therapeutics
15. Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro‐oesophageal reflux in patients with oesophagitis: a double‐blind, placebo‐controlled study
    Nonko Pehlivanov, Irene Sarosiek, Robert A. Whitman · 2002 · Alimentary Pharmacology & Therapeutics
16. The Absence of Tryptophan Hydroxylase Activity in Blood Platelets
    Jeremiah J. Morrissey, Margaret Walker, Walter M. Lovenberg · 1977 · Experimental Biology and Medicine
17. Lipid‐induced colonic hypersensitivity in irritable bowel syndrome: the role of 5‐HT3 receptors
    Magnus Simrén, Lorinda Simms, Doreen L. D'Souza, Hasse Abrahamsson, Einar S. Björnsson · 2003 · Alimentary Pharmacology & Therapeutics
18. Differential localization of 5-hydroxytryptamine3 and 5-hydroxytryptamine4 receptors in the human rectum
    Yasuko Sakurai‐Yamashita, Kimihiro Yamashita, Masaya Yoshimura · 1999 · Life Sciences
19. Desensitization of the peristaltic reflex induced by mucosal stimulation with the selective 5-HT4agonist tegaserod
    John R. Grider · 2005 · American Journal of Physiology-Gastrointestinal and Liver Physiology
20. Neuronal location of 5-hydroxytryptamine3 receptor-like immunoreactivity in the rat colon
    Christophe Mazzia, Gareth A. Hicks, Nadine Clerc · 2003 · Neuroscience
21. Sumatriptan is an agonist at 5‐HT1P receptors on myenteric neurones in the guinea‐pig gastric antrum
    Jan F. Tack, Pieter Vanden Berghe, Bernard J. Coulie · 2006 · Neurogastroenterology & Motility
22. Enterochromaffin Cells and 5-Hydroxytryptamine in the Human Intestinal Tract
    Antti Penttilä, M Lempinen · 1968 · Gastroenterology
23. Paroxetine in Patients With Irritable Bowel Syndrome
    Prakash S. Masand, Sanjay Gupta, Thomas L. Schwartz, Subhdeep Virk, Kari Lockwood, Ahmad Hameed, Monica King, David S. Kaplan · 2002 · The Primary Care Companion For CNS Disorders
24. The effect of cisapride on oesophageal motility and lower sphincter function in patients with gastro-oesophageal reflux disease
    Caterina A. Finizia, Lars R. Lundell, Lars Cange · 2002 · European Journal of Gastroenterology & Hepatology
25. Reduced expression of serotonin receptor (SR) in the left colon of patients with colonic inertia (CI)
    Rong-Hua Zhao, Khurrum M. Baig, K. Thaler, J. Mack, S. Abramson, S. Woodhouse, H. Tamir, E. Weiss, J. Nogueras, S. Wexner · 2000 · American Journal of Gastroenterology
26. Nicotinic and muscarinic modulation of 5-hydroxytryptamine (5-HT) release from porcine and canine small intestine
    K. Rack�, H. Schw�rer · 1992 · Journal of Molecular Medicine
27. Management of Idiopathic, Diabetic and Miscellaneous Gastroparesis with Cisapride
    M C Champion · 1989 · Scandinavian Journal of Gastroenterology
28. Human serotonectin: A blood glycoprotein that binds serotonin and is associated with platelets and white blood cells
    H. Tamir, R. F. Payette, Yiyun Huang, K. P. Liu, Michael David Gershon · 1985 · Journal of Cell Science
29. Age-Related Neurodegenerative Changes and How They Affect the Gut
    Paul R. Wade, Pamela J. Hornby · 2005 · Science of Aging Knowledge Environment
30. Distribution of serotonin (5-hydroxytryptamine) in the human gastroinetestinal tract.
    Takayoshi Tobe, M Fujiwara, Chie Tanaka · 1966 · PubMed
31. Effects of the 5‐HT3 receptor antagonist ICS 205‐930 on fat‐delayed gastric emptying and antral motor activity.
    Georg Stacher, Helmar Bergmann, C. Schneider, Gerda Mittelbach, Gabriele Gaupmann, Hermann Steinringer, Thalia-Anthi Abatzi, Giselheid Stacher-Janotta · 1990 · British Journal of Clinical Pharmacology
32. Antinociceptive property of tegaserod in a rat model of chronic visceral hypersensitivity
    Lie Xin Liang, Qing ZHANG, Wei Qian · 2005 · Chinese Journal of Digestive Diseases
33. Regionally selective cholinergic stimulation by BRL 24924 in the human isolated gut.
    T M Burke, Gareth John Sanger · 1988 · British Journal of Clinical Pharmacology
34. Alosetron withdrawn from market
    Cheryl A. Thompson · 2001 · American Journal of Health-System Pharmacy
35. Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome
    Prakash S. Masand, Sanjay Gupta, Thomas L. Schwartz, Subhdeep Virk, Ahmad Hameed, David S. Kaplan · 2005 · The Primary Care Companion For CNS Disorders
36. Effects of Tropisetron, a 5-HT3 Receptor Antagonist, on Proximal Gastric Motor and Sensory Function in Nonulcer Dyspepsia
    Stefan Klatt, Wolfgang Böck, Jochen Rentschler · 1999 · Digestion
37. Human pharmacology of renzapride: a new gastrokinetic benzamide without dopamine antagonist properties
    D. H. Staniforth, Michael Pennick · 1990 · European Journal of Clinical Pharmacology
38. Heterotrophic nitrification by intestinal microorganisms
    R.F. Gomez, Steven R. Tannenbaum, John Savoca, Dina Ralt, Neal L. Rockowitz · 1980 · Cancer
39. The effect of the selective 5-HT3 receptor agonist on ferret gut motility
    Yukinori Nagakura, Tetsuo Kiso, Keiji Miyata · 2002 · Life Sciences
40. Glucuronidation of 5-hydroxyindole derivatives in vitro
    M.M. Airaksinen, T.A. Miettinen, Jussi K. Huttunen · 1965 · Biochemical Pharmacology
41. Modulation of Intestinal Gas Dynamics in Healthy Human Volunteers by the 5-HT 4 Receptor Agonist Tegaserod
    Radoslav Coleski, Chung Owyang, William Lee Hasler · 2006 · The American Journal of Gastroenterology
42. Effects of nutrients and serotonin 5-HT 3 antagonism on symptoms evoked by distal gastric distension in humans
    Uri Ladabaum, Morton B. Brown, Wenqin Pan · 2001 · American Journal of Physiology-Gastrointestinal and Liver Physiology
43. Review article: evaluation of drugs in experimental gut distension models
    Theodore Nick Pappas, Allen W. Mangel, C. Lawson · 1999 · Alimentary Pharmacology & Therapeutics
44. Metabolism of 5-Hydroxytryptophan in Isolated Perfused Intestine from Normal and X-Irradiated Rat
    GEORG B. GERBER, J. Deroo, A. Mazanowska · 1972 · Archives Internationales de Physiologie et de Biochimie
45. Differential distribution of 5-hydroxytryptamine3 receptor in the colon between human and guinea pig.
    Yasuko Sakurai‐Yamashita, Kimihiro Yamashita, Muneshige Kaibara · 1999 · PubMed
46. Double blind placebo controlled study on the effect of the nitric oxide donor molsidomin and the 5-HT3 antagonist ondansetron on human esophageal motility.
    S Willis, H. D. Allescher, B. Stoschus · 1994 · PubMed
47. The effects of lintopride, a 5HT‐4 antagonist, on oesophageal motility
    Michel Delvaux, J.‐M. MAISIN, Y Arany · 1995 · Alimentary Pharmacology & Therapeutics
48. Gastrointestinal neuropharmacology: identification of therapeutic targets
    John B. Furness · 2002 · Current Opinion in Pharmacology
49. Effects of the 5-HT3 receptor antagonist, ICS 205-930, on oesophageal motor activity and on lower oesophageal sphincter pressure: a double-blind cross-over study.
    Georg Stacher, G.E. Steiner, G Guapmann · 1990 · PubMed
50. Connectional networks within the orbital and medial prefrontal cortex of macaque monkeys
    Carmichael, S.T., Price, J.L. · 1996 · Journal of Comparative Neurology